CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 265 enrolled
Drug / intervention
Placebo +2 moredrug
Likely dose
Guaifenesin 400 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01062256
NCT01062256N/ACompleted

A Methodology Study to Assess Cough Counts in Subjects With Acute Upper Respiratory Tract Infections

Wyeth is now a wholly owned subsidiary of Pfizer·interventional·Posted Feb 4, 2010·Updated Feb 25, 2013

In Brief

A clinical study evaluating Placebo, Guaifenesin, and 1 other intervention for Infection. Completed, enrolled 265 participants across 2 sites.

Detailed Summary

The objectives of this study are: a) to assess the feasibility and sensitivity of manually count cough bouts over a 4-hour period; b) to assess the effects of buckwheat honey and guaifenesin 400 mg immediate release tablets compared to placebo on the frequency and severity of acute cough due to upper respiratory tract infection and c) to evaluate the correlation between cough bout frequency and subjective assessments of cough severity. The hypotheses to be tested is that 10 ml of buckwheat honey and 400 mg of immediate release guaifenesin will significantly reduce the frequency and severity of cough compared to placebo over a 4-hour evaluation period.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfection
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 4, 2010
Enrollment StartJan 1, 2010
Primary CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 16.4 years ago

Interventions

Placebodrug

One placebo tablet administered orally as a single dose

Guaifenesindrug

One 400 mg immediate release tablet administered orally as a single dose

Buckwheat Honeyother

10 mL administered orally as a single dose